ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 393

$667K Total Retail Price of All Prescriptions

Rank: 32 out of 393

1,004 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,004 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 1,004 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,869 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,066 1,024 1 1
LEVOTHYROXINE SODIUM 928 864 2 3
OMEPRAZOLE 874 838 3 6
LISINOPRIL 747 716 4 2
CITALOPRAM HBR 723 657 5 23
HYDROCODONE-ACETAMINOPHEN 556 476 S3 6 5
ALENDRONATE SODIUM 510 484 7 16
AMLODIPINE BESYLATE 471 443 8 4
METFORMIN HCL 459 423 9 7
ATENOLOL 417 408 10 13
HYDROCHLOROTHIAZIDE 411 392 11 10
FUROSEMIDE 347 322 12 8
GABAPENTIN 279 254 13 15
ZOLPIDEM TARTRATE 257 238 14 11
POTASSIUM CHLORIDE 220 219 15 20
WARFARIN SODIUM 217 204 16 17
LOVASTATIN 198 190 17 14
DONEPEZIL HCL 188 188 18 34
FLUTICASONE PROPIONATE 182 170 19 27
METOPROLOL TARTRATE 170 167 20 9
LOSARTAN POTASSIUM 161 152 21 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 141 22 24
TRAMADOL HCL 134 126 23 30
CARVEDILOL 130 123 24 21
TERAZOSIN HCL 124 124 25 38
GLYBURIDE 123 118 R 26 46
METOPROLOL SUCCINATE 118 114 27 22
VENTOLIN HFA 113 76 28 42
FLUOXETINE HCL 110 105 29 37
OXYBUTYNIN CHLORIDE 104 104 30 90
EVISTA 101 101 31 98
TRIAMTERENE-HCTZ 100 89 32 49
CLOPIDOGREL 100 95 32 33
PRAVASTATIN SODIUM 96 94 34 18
LANTUS SOLOSTAR 90 87 35 74
ALLOPURINOL 85 85 36 26
PAROXETINE HCL 84 83 37 61
PEN NEEDLE 83 74 38 81
SYMBICORT 82 82 39 96
RANITIDINE HCL 82 73 39 29
DIGOXIN 81 81 41 66
ATORVASTATIN CALCIUM 79 62 42 19
BACLOFEN 79 75 42 79
AMITRIPTYLINE HCL 79 66 R 42 72
SERTRALINE HCL 78 78 45 28
PROPRANOLOL HCL 72 72 46 134
PLAVIX 69 68 47 51
QVAR 65 60 48 101
NIFEDIPINE ER 64 64 49 91
LEVOXYL 63 61 50 120
DILTIAZEM ER 62 59 51 107
SPIRIVA 60 57 52 41
BENAZEPRIL HCL 59 59 53 40
LOSARTAN-HYDROCHLOROTHIAZIDE 58 56 54 31
ACTOS 57 54 55 78
NAPROXEN 56 56 56 85
NAMENDA 54 54 57 59
GLIPIZIDE 53 50 58 32
LANTUS 53 53 58 73
CLONIDINE HCL 52 42 60 50
GEMFIBROZIL 51 51 61 62
IBUPROFEN 51 45 61 55
METFORMIN HCL ER 50 48 63 63
BISOPROLOL FUMARATE 50 35 63 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.